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UMass CHRC Research Objectives: 
Colon Health Initiative  
• Dietary cranberry and inflammatory colon cancer
• Mouse model study published – Xiao and Neto
• Content and distribution of “bioactive” cranberry compounds in fruit 
and products
• Ongoing studies by Neto research group
• New Colon Health Initiatives funded by Albert Charitable Trust & MA
• Cranberry, gut microbes and immune system - Vanni Bucci
• Nanoscale targeted delivery of cranberry compounds – Milana Vasudev
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Effect of cranberry on colon cancer and 
inflammation in a mouse model
Hang Xiao (UMass Amherst, Food Science)
Cathy Neto (UMass Dartmouth)
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Study Objectives
• Earlier studies showed that 
several cranberry compounds 
decrease tumor cell growth
• Here, we evaluated effect of 
cranberry-supplemented diets 
in a mouse model of colitis-
associated colon cancer 
• Measure tumors and 
inflammation in mouse colon 
in response to treatments
Polar extract 
(PACs, 
quercetin, 
anthocyanin)
Nonpolar 
extract
(Ursolic acid,
lutein)
Cranberry
powder
Experimental design of 
mouse feeding study
Control Diet
(AIN-93G)
Cranberry 
Powder
(1.5%)
Polar
extract ( 0.1%)
Mice age
(weeks) 5        6          7         8          9        10        11       12        13       14                                   27 
Non Polar 
extract
( 0.05%)
AOM
DSS DSS DSS DSS
After 20 weeks on diet 
mice are sacrificed.
Number and volume of 
colon tumors was 
assessed. 
Tissues analyzed for 
changes in markers of 
inflammation and 
carcinogenesis.
n = 20
Whole cranberry powder reduced tumors, 
inflammation in mice by up to 50%  
• Article published in Molecular Nutrition & Food Research, Dec. 2018
• AOM/DSS-treated mice mimic colitis, a colon cancer risk factor
• 20 weeks on CB diet (1.5% w/w WCP in AIN93G chow), n = 20
• Equivalent to 3/4 cup or 75 g/day fresh fruit for a person weighing 150 lbs
• Outcomes measured:
• Tumor size and number
• Inflammatory gene and protein expression in colon tissue
• Markers of cell proliferation, apoptosis, angiogenesis, metastasis 
• Effects are likely due to multiple compounds in cranberry fruit
• PACs (6%), Anthocyanins (2%), Ursolic & Oleanolic Acids (1%)
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Group Control Colitis
model
Colitis + 
cranberry 
Colon length 
(mm)
96.6 + 2.4 87.8 + 2.9 92.7 + 3.0
Tumor incidence 0 80% 50%
Tumors/mouse 0 5.91 + 1.0 2.77 + 0.88
Tumor burden 
(vol/mouse mm3)
0 17.7 + 2.5 4.64 + 1.26
Tumor volume 0 18.8 + 1.9 10.3 + 1.3
COX-2 expression 
(fold change)
0 1 0.3
Cyclins/kinases 0 1 0.25-0.75 
Metastasis
markers (MMPs)
0 1 0.05-0.60
Anti-cancer mechanisms observed in vivo are 
consistent with those observed in cranberry-treated 
prostate cancer cells (Hurta & Neto)
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Whole cranberry powder significantly 
reduced multiple cancer markers  
All three cranberry preparations 
significantly reduced tumors
Average tumor number per mouse Average total tumor volume in colon
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Results indicate that a combination of different “bioactives” may support gut health
We need to better understand interactions with bacteria, immune system & tissues
Cranberries and products as a source of 
gut-healthy “bioactives” 
• PACs 
• Anthocyanins
• Ursolic and Oleanolic Acid
• Quercetin
• Complex carbohydrates from 
fiber 
• 10 cultivars of cranberry fruit 
harvested in MA & OR (Liang Xue)
• Stevens, Mullica Queen, Crimson 
Queen, Demoranville, Early Black, 
Pilgrim, Welker, Scarlet Knight, GH1
• 10 commercial cranberry 
“supplements” from various 
suppliers (John Turbitt)
Cranberry
Health     
Research 
Center
Cranberry supplements vary in 
composition and quality (J. Turbitt)
“Cranberry” or not so much?
Chemometric analysis of ten 
commercial products by NMR
• Less than half of products tested
were comparable to whole 
cranberry powder model (WCP)
• Most supplements were far lower 
in bioactives content than WCP
• Ursolic and oleanolic acid 
• Total PACs
• Quercetin, anthocyanins
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WCP
Content of bioactives in cranberry 
fruit from MA cultivars (L. Xue)
Total PACs content Ursolic and Oleanolic acid
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Similar data in 2016 No clear cultivar trends, but higher in 2016
Mullica Queen
Early Black
Pilgrim 
were tops!
n = 5 n = 5
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Average Cranberry Bioactives Content, 
Regional Comparison (2016-2017) 
MA OR
MA ORMA OR
MA OR  
MA ≈ OR MA >> OR  
OR >> MA OR > MA        
n = 45
Bioengineering to 
optimize cranberry 
targets in colon 
and gut   
Targeted delivery of cranberry 
bioactives
• Encapsulation of cranberry 
compounds with micellar, 
liposome or peptide-based 
carriers
• May enhance bioavailability 
of these compounds 
• Goal: target tumors in vivo
Interactions of cranberry with 
gut microbiome
• Using a computational approach 
to analyze changes in gut 
microbial community & tissues 
in response to cranberry
• Cranberry as “prebiotic” could 
boost population of probiotic or 
“good” bacteria in the gut
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Next steps: Modeling the gut and its response to 
delivery of cranberry “bioactives”
• Mouse model of gut microbiome
• Team plans to study interactions 
between microbes, colon tissues 
when treated with cranberry 
• Our aim is to provide data for 
proposals to NIH, others 
• Challenge: state funding has a 
strict FY deadline and 6 month 
“window” for expenditures 
Cranberry
Health     
Research 
Center
E. coli S. aureus S. Typhimurium
0 300 600 900 0 300 600 900 0 300 600 900
0.00
0.25
0.50
0.75
1.00
Minutes
Op
tic
al 
De
ns
ity PAC
0
0.0018
0.018
0.18
Cranberry
Health     
Research 
Center
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and Ben Jones 
State of MA (DPH)
Senator Rodrigues
Rep. Strauss
CCCGA
UMass Cranberry Station
OSU Cranberry Station 
Liang Xue
John Turbitt
Anuradha Tata
Ryan Magina
Hang Xiao
Xian Wu
Vanni Bucci
Milana Vasudev
